Imricor Medical Systems, Inc. · ASX:IMR
Imricor Medical Systems — Shareholder Meeting (May 2020)
16 slides from Imricor Medical Systems's shareholder meeting presentation, May 13, 2020
Slide 1: Welcome to the Imricor Annual Meeting
rsonal use only Welcome to the Wednesday, 13 May 2020 (AEST) Imricor Annual Meeting Tuesday, 12 May 2020 (CDT)
Slide 2: Please submit questions at any time throughout the meeting
Please submit questions at any time throughout the meeting • When the question function is available, the rsonal use only Q&A icon will appear at the top of the app. • To send in a question, simply click in the ‘Ask a question’ box, type your question and the press the send arrow • Your question wil
Slide 3: Voting online at the virtual meeting
Voting online at the virtual meeting • When the poll is open, the vote will be rsonal use only accessible by selecting the voting icon at the top of the screen • To vote simply select the direction in which you would like to cast your vote, the selected option will change colour. • There is no submi
Slide 4: Imricor's Board of Directors
rsonal use only Imricor’s Board of Directors Steve Wedan Mark Tibbles Doris Engibous Peter McGregor President and CEO, Non-executive Director Non-executive Director Non-executive Director and Chair 4 Imricor Annual Meeting 2020
Slide 5: Chair's Address
Chair’s Address rsonal use only 5 Imricor Annual Meeting 2020
Slide 6: Commercial launch – first procedures at Dresden Heart Centre
rsonal use only Commercial launch – first procedures at Dresden Heart Centre Dr. Christopher Piorkowski and Dr. Thomas Gaspar performing initial procedures at the Dresden Heart Centre 6 Imricor Annual Meeting 2020
Slide 7: Active catheter imaging supporting lab adoption
rsonal use only Active catheter imaging supporting lab adoption Vision-MR Ablation Active Catheter Imaging Provides Catheter tip • Fluoroscopic-like MR imaging with easily identified catheter tip • Increased speed for AFL ablations compared to active tracking and mapping • Enhanced speed of adoption
Slide 8: Lab roll out plans stalled by COVID-19
Lab roll out plans stalled by COVID-19 Key lab • Dresden: Routine clinical procedures commenced in January operational rsonal use only • Haga: Adv-MR installed 3 Sites with • UMC Ams: Adv-MR installed Signed Contracts • Leipzig: Adv-MR installed 7 Sites with Agreements in • In final stages of the sa
Slide 9: Adapting to COVID-19 – launch of first online educational seminar
rsonal use only Adapting to COVID-19 – launch of first online educational seminar 9 Imricor Annual Meeting 2020
Slide 10: Master purchasing agreement with Sana
rsonal use only Master purchasing agreement with Sana Sana is the largest Group Purchasing Organisation in Germany • 600 cooperating hospitals and medical institutions across Germany and Switzerland • 80 of these sites perform cardiac catheter ablations – potential Imricor customers • Streamlines co
Slide 11: Product line expansion - improve gross margin, support expanding indications
Product line expansion - improve gross margin, support expanding indications Steerable Sheath and Diagnostic Catheter Transseptal Needle rsonal use only • Prototype phase • Regulatory strategy being developed • Fully staffed execution • Aiming to be ready for clinical trials in 2021 • Development we
Slide 12: A phased approach to geographic expansion
rsonal use only A phased approach to geographic expansion EU Australia US Local agent to be selected in near term. Europe CE mark achieved Detailed approval strategy United States in planning phase. PHASE 1 FDA strategy well The Netherlands, Austria, advanced. Germany and Switzerland. Targeting next
Slide 13: Growing the team to deliver growth opportunities and support product roll out
rsonal use only Growing the team to deliver growth opportunities and support product roll out FTEs at IPO FTEs Today G&A G&A Manufacturing 2 5 4 Manufacturing 11 Sales & Marketing 1 Total 25 Total 43 Sales & Marketing Reg & Quality R&D 5 3 R&D 18 14 Reg & Quality 5 13 Imricor Annual Meeting 2020
Slide 14: Imricor's Board of Directors
rsonal use only Imricor’s Board of Directors Steve Wedan Mark Tibbles Doris Engibous Peter McGregor President and CEO, Non-executive Director Non-executive Director Non-executive Director and Chair 14 Imricor Annual Meeting 2020
Slide 15: Thank you for your support
rsonal use only Thank you for your support 15 Imricor Annual Meeting 2020
Slide 16: Disclaimer
Disclaimer The material contained in this presentation is intended to be general background information on Imricor Medical Systems Inc (“Imricor”) and its activities. The information is supplied in summary form and is therefore not necessarily complete. It is not intended that it be relied upon as a
Imricor Medical Systems — Shareholder Meeting (May 2020) on 6ix